Introduction
The efficacy of co-trimoxazole in the treatment of granuloma venereum was studied in 10 cases by Garg et al. 1 Co-trimoxazole appears to be as effective as, if not more so than, streptomycin or tetracycline. It shares with streptomycin the advantage of not masking a concomitant early syphilitic infection.2 Side effects of co-trimoxazole were negligible compared with those of streptomycin, which produces giddiness in about 16% of patients with the dosage used for this disease.3 Another advantage is that it is also effective against gonorrhoea4 and lymphogranuloma venereum,5 whereas streptomycin is not effective against either of these diseases. Lastly, ease of administration of the drug is another advantage over streptomycin, for which twice daily injections are required.
Co-trimoxazole can thus be considered to be the drug of choice for the treatment of granuloma venereum in a dose of two tablets twice daily for 10-15 days. Its higher cost compared with that of streptomycin hinders its recommendation as the routine treatment for the disease.
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